Mid-Cap Growth · NYSE ARCA · USD · Data as of 2026-05-15
AUM
$87.69M
Expense ratio
0.80%
Yield
1.23%
YTD return
+9.34%
Last price
$42.16
Thematic Sector · Coverage 50% · low
Today
46.4
Outlook
43.0
Block A (composite-derived)
35.3
Block C (market behavior)
47.7
Today overlay (Block D)
0.0
Outlook overlay (Block D)
0.0
today_score = clip(0,100, 50 + 0.15·(A−50) + 0.60·(C−50) + D_today). Block B (holdings rollup) is in Phase 3 development; β=0 caps the natural range at ~12.5–87.5 in Preview v0.9. Formula version tide-etf-v1.0.0.
35.3
Coverage 50% · low
Liquidity
—
Expenses
45.0
Performance
—
Volatility
8.5
Dividend
41.1
Concentration
55.0
Smart Money
—
Activist
—
Formula version composite-v1.0.0. Axes hover to see why a sub-score is missing.
Innovator IBD® 50 ETF (FFTY) is an exchange-traded fund from Capital-FORCE ETF in the Mixed asset class. Launched in 2015. Assets under management: 87,688,968.
The fund tracks the IBD 50 Index.
Bullish Whales composite rating: 35 out of 100. Evidence coverage 50% across 4 of 8 axes. Strongest axes: concentration, expenses, dividend.
Annualized one-year realized volatility 35%, classified high. Weakest axes: volatility, dividend.
Top-10 weight 0%, diversified, led by ANAB. Trailing yield 0%.
etf_composite_score_current · composite_score, concentration_score, confidence, coverage_pct, dividend_score, expenses_score, volatility_scoreetf_fundamentals_td · dividend_frequency, yieldetf_holdings_top10 · holding_symbol, weightetf_universe · asset_class, aum_usd, benchmark, benchmark_provider, fund_type, inception_date, issuer, name, replication_method, ticker, volatility_1yThe Innovator IBD 50 ETF is an exchange-traded fund designed to track the performance of the IBD 50 Index. The primary purpose of this ETF is to provide investors with exposure to a diversified basket of stocks representing high-growth companies. The IBD 50 Index is composed of leading growth stocks selected based on fundamental and technical criteria by Investor's Business Daily. This ETF is significant for its focus on dynamic companies across various sectors that are characterized by strong earnings, sales growth, and other quantitative factors. The ETF aims to offer investors a strategic vehicle to access some of the market's most promising growth stories without the need to individually select and manage the stocks. The Innovator IBD 50 ETF plays a crucial role for both individual and institutional investors seeking growth-oriented holdings within their equity portfolio. By encompassing multiple sectors like technology, healthcare, and consumer goods, this ETF provides a balanced approach to capturing growth potential while mitigating risks associated with concentrating in one domain.
Net AUM change history is not yet available for this ETF. Fund-flow time series is a Phase B deliverable.
Current AUM: $87,688,968. AUM change is computed from rolling daily fundamentals snapshots; it reflects total net-asset deltas (creations/redemptions + market value moves), not pure share creations.
Fund documents (fact sheets, prospectuses, semi-annual reports) for FFTY are coming soon. The BW fund-document archive will surface PDFs alongside a metadata index for searchability.